BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $13.65 million. The enterprise value is $13.11 million.

Market Cap	13.65M
Enterprise Value	13.11M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, before market open.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 11.37 million shares outstanding. The number of shares has increased by 135.69% in one year.

Current Share Class	11.37M
Shares Outstanding	11.37M
Shares Change (YoY)	+135.69%
Shares Change (QoQ)	+1.27%
Owned by Insiders (%)	19.97%
Owned by Institutions (%)	13.08%
Float	8.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.41

Current Ratio	0.41
Quick Ratio	0.35
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-252.00%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	733.40%
Weighted Average Cost of Capital (WACC)	6.81%
Revenue Per Employee	n/a
Profits Per Employee	-$370,238
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.67% in the last 52 weeks. The beta is 0.50, so BioCardia's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-46.67%
50-Day Moving Average	1.02
200-Day Moving Average	1.25
Relative Strength Index (RSI)	68.40
Average Volume (20 Days)	8,600,651

Short Selling Information

The latest short interest is 438,565, so 3.86% of the outstanding shares have been sold short.

Short Interest	438,565
Short Previous Month	329,380
Short % of Shares Out	3.86%
Short % of Float	5.01%
Short Ratio (days to cover)	0.06

Income Statement

Revenue	n/a
Gross Profit	-4.67M
Operating Income	-7.82M
Pretax Income	-7.78M
Net Income	-7.78M
EBITDA	-7.80M
EBIT	-7.82M
Earnings Per Share (EPS)	-$0.95

Full Income Statement

Balance Sheet

The company has $951,000 in cash and $412,000 in debt, giving a net cash position of $539,000 or $0.05 per share.

Cash & Cash Equivalents	951,000
Total Debt	412,000
Net Cash	539,000
Net Cash Per Share	$0.05
Equity (Book Value)	-1.07M
Book Value Per Share	-0.10
Working Capital	-1.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.48 million and capital expenditures -$10,000, giving a free cash flow of -$7.49 million.

Operating Cash Flow	-7.48M
Capital Expenditures	-10,000
Depreciation & Amortization	15,000
Net Borrowing	n/a
Free Cash Flow	-7.49M
FCF Per Share	-$0.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-135.69%
Shareholder Yield	-135.69%
Earnings Yield	-56.96%
FCF Yield	-54.85%

Analyst Forecast

The average price target for BioCardia is $15.50, which is 1,191.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	1,191.67%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2